Better Health through Amplified Intelligence

amplified intelligence

Our Technology Platform

SANSHI Bio Solutions’ proprietary platform technology, Polyspecific Therapeutics for Immunomodulation (PTIm™), delivers first-in-class or best-in-class therapeutics in Oncology and Autoimmune diseases.

SANSHI offers Therapeutics Design & Optimization services utilizing Amplified Intelligence to design novel therapeutics tailored to specific physiological and biological pathways.

Expedite Research & Development

By analyzing drug-target interactions with high precision, we accelerate the path from design to discovery.

Best-in-Class Therapeutics

We design best-in-class poly-pharmacological therapeutics that are expected to be synergistic and less toxic with greater patient compliance.

Rational Drug Discovery

We adopt the principles of GOT-IT framework (Guided Options for Target-IT) as well as 5 R’s to validate drug targets focusing on addressing safety issues, druggability, assayability, and disease relevance.

SANSHI-AIM™

SANSHI Bio Solutions delivers faster, smarter immunomodulatory therapies by integrating expertise and innovation through SANSHI-AIM™, a vital component tool of the PTIm™ platform.
sanshi aim

This platform embodies our vision and mission, embeds our core values, and is designed to address unmet medical needs—enabling patients to benefit from innovative therapies at the earliest possible stage.

Bespoke Services

cell culture at the medicine, medical and cell culture laboratory

In-vitro Studies for NBE, NCE, NA Screening

We have expertise in performing Cell based Assays, Ligand Binding Studies, Determination of Potency in 3D Spheroids and Organoids, Functional Studies and PROTACS Screening.

antibodies to cell movement of the virus

Biosimilars & Generic Therapeutics

For development of biosimilars and generic therapeutics, we perform Bioassays, Binding Affinity (ELISA,SPR), with primary focus on Single clone isolation and Clonal Stability.

invitro home

In-vitro ADMET

We evaluate physico-chemical properties, absorption, metabolic stability, drug metabolism, drug-drug interactions, and toxicity.

in vivo900x600

In-vivo Studies (Preclinical Pharmacology)

We perform in-vivo studies in Subcutaneous Tumor Models (both Syngeneic and CDX,PDX Xenografts), in addition to Chronic Wound, Allergy and Inflammation Models.

ira900x600

Immunogenicity Risk Analysis (IRA)

We perform specialized HLA differentiated assays for assessment of adaptive and innate Immunity and Anti-Drug Antibodies.

strategic consulting

Strategic Consulting & Project Management

Leverage our team’s collective proven expertise of developing molecules that advanced into clinical stage and market approval.

Rethink Your Drug Discovery and Development Projects

Leverage our Amplified Intelligence  for optimized design and development of therapeutics

Sanshi Logo T429x282 130x85

True to its Sanskrit origin—signifying refinement and mastery—SANSHI is guided by four pillars: Integrity, Quality, Expertise, and Excellence.

Follow Us
Scroll to Top